Lanreotide (Mytolac) all strengths: Supply issue
There is limited stock available of any strength of the Mytolac brand lanreotide injection.
14 January 2026 | Somatuline Autogel available
The supplier has Somatuline Autogel available for wholesalers to order. Pharmacies may need to contact wholesalers to request this product.
Affected products
Due to issues at the manufacturing plant, the supplier currently has no stock available of the following products. There may be some stock available at wholesalers and pharmacies.
| Presentation | Brand | Pharmacode | Subsidy | Measure/Quantity |
|---|---|---|---|---|
| Inj 60 mg per 0.5 ml, 0.5 ml syringe | Mytolac | 2698145 | $382.77 | per 1 |
| Inj 90 mg per 0.5 ml, 0.5 ml syringe | Mytolac | 2698153 | $562.92 | per 1 |
| Inj 120 mg per 0.5 ml, 0.5 ml syringe | Mytolac | 2698161 | $646.70 | per 1 |
Schedule listing for lanreotide(external link)
HML listing for lanreotide(external link)
Alternatives
We have urgently sourced an alternative brand, Somatuline Autogel, and it was funded from 1 January 2026.
Datasheet: Mytolac Solution for injection | Medsafe(external link) (pdf 929KB)
CMI: Mytolac Solution for injection | Medsafe(external link) (pdf 512KB)
Datasheet: Somatuline Autogel Solution for injection | Medsafe(external link) (pdf 496KB)
CMI: Somatuline Autogel Solution for injection | Medsafe(external link) (pdf 277KB)
Listing information
|
Chemical |
Formulation |
Brand |
Pharmacode |
Subsidy |
Pack size |
|---|---|---|---|---|---|
|
Lanreotide |
Inj 60 mg per 0.5 ml, 0.5 ml syringe |
Somatuline Autogel |
2720264 |
$1,543.79 |
per 1 |
|
Lanreotide |
Inj 90 mg per 0.5 ml, 0.5 ml syringe |
Somatuline Autogel |
2720272 |
$2,054.40 |
per 1 |
|
Lanreotide |
Inj 120 mg per 0.5 ml, 0.5 ml syringe |
Somatuline Autogel |
2659131 |
$2,570.44 |
per 1 |
People who use lanreotide
You may need to talk to the person who prescribed your lanreotide about the best way to respond to this supply issue.
Somatuline Autogel
The injection for Somatuline Autogel may look a little different from Mytolac. Read the instructions carefully before administering it.
Flyer for pharmacists
- Lanreotide supply issue flyer | Dec 25 [PDF 77 KB]
Expected resupply
We are working with the supplier to understand when the Mytolac brand will be available again.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)
Pharmac is a government agency. We do not sell medicines or related products.